I. Rudolph

Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression

I. Rudolph, E. Palombo-Kinne, B. Kirsch, 2004, Climacteric : the journal of the International Menopause Society.

Can Patients Diagnosed with Schizophrenia Complete Choice-Based Conjoint Analysis Tasks?

J. Bridges, A. Mühlbacher, E. Kinter, 2011, The patient.

Preferences for treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): a discrete choice experiment

M. Nübling, A. Mühlbacher, I. Rudolph, 2009, BMC health services research.

Identifying patient-relevant endpoints among individuals with schizophrenia: An application of patient-centered health technology assessment

J. Bridges, S. dosReis, E. Kinter, 2009, International Journal of Technology Assessment in Health Care.

Changes in psychic and somatic well-being and cognitive capabilities of peri- and postmenopausal women after the use of a hormone replacement drug containing estradiol valerate and levonorgestrel.

T. Zimmermann, I. Rudolph, H. Ahrendt, 2000, Methods and Findings in Experimental and Clinical Pharmacology.